QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$1.18
+1.7%
$2.06
$0.39
$18.00
$5.50M3.523,038 shs6,887 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.57
+2.5%
$0.46
$0.37
$1.62
$2.78M0.45383,937 shs47,446 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$0.04
-1.8%
$0.10
$0.02
$2.13
$891K1.4620.38 million shs33.87 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
+2.33%-19.80%-40.20%-76.59%-66.09%
Dynatronics Co. stock logo
DYNT
Dynatronics
-4.91%+39.08%+28.48%+3.11%-62.41%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
+7.24%+60.64%-69.23%-86.48%-98.09%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
1.8588 of 5 stars
3.05.00.00.02.50.00.6
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
2.00
Hold$3.80566.67% Upside
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.00
HoldN/AN/A

Current Analyst Ratings

Latest DYNT, ARTH, and SINT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/5/2024
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$80K69.92N/AN/A($2.43) per share-0.49
Dynatronics Co. stock logo
DYNT
Dynatronics
$40.61M0.07N/AN/A$2.19 per share0.26
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$2.63M0.34N/AN/A$1.65 per share0.02

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
-$6.98MN/A0.00N/A-6,809.45%N/A-386.74%5/20/2024 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$4.97M-$1.38N/AN/A-14.13%-54.88%-16.14%5/9/2024 (Estimated)
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$8.26M-$3.42N/AN/A-314.39%-67.12%-45.49%5/20/2024 (Estimated)

Latest DYNT, ARTH, and SINT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/27/2024Q4 2023
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A-$0.09-$0.09-$0.09N/A$0.90 million
2/20/2024Q1 2024
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A-$0.57-$0.57-$0.57N/A$0.05 million
2/7/2024Q2 2024
Dynatronics Co. stock logo
DYNT
Dynatronics
N/A-$0.27-$0.27-$0.27N/A$8.15 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A
0.16
0.04
Dynatronics Co. stock logo
DYNT
Dynatronics
0.21
1.41
0.67
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
1.90
1.60

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
6.91%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%

Insider Ownership

CompanyInsider Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
4.50%
Dynatronics Co. stock logo
DYNT
Dynatronics
9.10%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
1.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
84.74 million4.53 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
1544.88 million4.44 millionNot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
4122.68 million22.45 millionNot Optionable

DYNT, ARTH, and SINT Headlines

SourceHeadline
Why SINTX Technologies Stock Is Getting HammeredWhy SINTX Technologies Stock Is Getting Hammered
msn.com - April 3 at 2:48 PM
SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock
globenewswire.com - April 3 at 9:00 AM
Why SINTX Technologies Stock Hit A New All-Time Low TodayWhy SINTX Technologies Stock Hit A New All-Time Low Today
msn.com - April 1 at 3:51 PM
DDC Appoints Vice President to Drive Operational ExcellenceDDC Appoints Vice President to Drive Operational Excellence
itnewsonline.com - March 30 at 6:23 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 29 at 4:00 PM
SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 28 at 7:02 AM
Sintx Technologies Prices Public Offering Of $1.3 Mln Of SharesSintx Technologies Prices Public Offering Of $1.3 Mln Of Shares
markets.businessinsider.com - March 25 at 1:22 PM
Why SINTX Technologies Stock Is Down 50%Why SINTX Technologies Stock Is Down 50%
msn.com - March 25 at 1:22 PM
Why Is Sintx Technologies (SINT) Stock Down 31% Today?Why Is Sintx Technologies (SINT) Stock Down 31% Today?
investorplace.com - March 25 at 9:05 AM
SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock
globenewswire.com - March 25 at 9:00 AM
US Stocks Edge Lower; FedEx Posts Upbeat EarningsUS Stocks Edge Lower; FedEx Posts Upbeat Earnings
msn.com - March 23 at 3:15 AM
Why SINTX Technologies Is Trading Higher TodayWhy SINTX Technologies Is Trading Higher Today
aol.com - March 22 at 10:14 PM
Gold Moves Lower; Lululemon Shares PlummetGold Moves Lower; Lululemon Shares Plummet
msn.com - March 22 at 5:14 PM
Dow Dips 200 Points; Nike Shares Fall After Q3 ResultsDow Dips 200 Points; Nike Shares Fall After Q3 Results
markets.businessinsider.com - March 22 at 5:14 PM
SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%
markets.businessinsider.com - March 22 at 5:14 PM
Why SINTX Technologies Stock Is NosedivingWhy SINTX Technologies Stock Is Nosediving
msn.com - March 22 at 5:14 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 22 at 8:30 AM
Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20
msn.com - February 24 at 2:14 PM
Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)
benzinga.com - February 23 at 7:50 AM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
finance.yahoo.com - February 21 at 3:58 PM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
globenewswire.com - February 21 at 9:00 AM
SINTX Technologies: Other EventsSINTX Technologies: Other Events
cbonds.com - February 16 at 10:37 AM
SINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturingSINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturing
tctmagazine.com - February 7 at 10:57 AM
Sintx Technologies just downgraded at Maxim, heres whySintx Technologies just downgraded at Maxim, here's why
realmoney.thestreet.com - February 5 at 5:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Arch Therapeutics logo

Arch Therapeutics

OTCMKTS:ARTH
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.
Dynatronics logo

Dynatronics

NASDAQ:DYNT
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Sintx Technologies logo

Sintx Technologies

NASDAQ:SINT
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.